![](/img/cover-not-exists.png)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
Bolinder, J., Ljunggren, Ö., Johansson, L., Wilding, J., Langkilde, A. M., Sjöström, C. D., Sugg, J., Parikh, S.Volume:
16
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12189
Date:
February, 2014
File:
PDF, 402 KB
english, 2014